MD Stock Recent News
MD LATEST HEADLINES
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Revvity (RVTY). But which of these two stocks presents investors with the better value opportunity right now?
Pediatrix's (MD) second-quarter earnings benefit from stable patient volumes. Rising expenses act as a partial offset.
Pediatrix Medical Group, Inc. (NYSE:MD ) Q2 2024 Earnings Conference Call August 6, 2024 9:00 AM ET Company Participants Charles Lynch - SVP, Finance & Strategy Jim Swift - CEO Marc Richards - CFO Kasandra Rossi - SVP, Financial Reporting & Assistant Treasurer Conference Call Participants A.J. Rice - UBS Nur Robleh - Jefferies Benjamin Shaver - Deutsche Bank Kevin Fischbeck - Bank of America Operator Ladies and gentlemen, thank you for standing by.
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.39 per share a year ago.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Second Quarter Results.
OKLAHOMA CITY--(BUSINESS WIRE)-- #FedermanSherwood--Federman & Sherwood Announces Preliminary Approval of Settlement in MedNax Services, Inc., Customer Data Security Breach Litigation.
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group To Present at Upcoming Investor Conferences.
Pediatrix's (MD) Q1 results benefit from higher same-unit revenues, resulting from growing patient volumes, partly offset by high costs. It continues to expect 2024 adjusted EBITDA within $200-$220 million.
The headline numbers for Pediatrix Medical Group (MD) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.